189 related articles for article (PubMed ID: 22236593)
1. Hormonal activities of new brominated flame retardants.
Ezechiáš M; Svobodová K; Cajthaml T
Chemosphere; 2012 May; 87(7):820-4. PubMed ID: 22236593
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic and androgenic activities of TBBA and TBMEPH, metabolites of novel brominated flame retardants, and selected bisphenols, using the XenoScreen XL YES/YAS assay.
Fic A; Žegura B; Gramec D; Mašič LP
Chemosphere; 2014 Oct; 112():362-9. PubMed ID: 25048928
[TBL] [Abstract][Full Text] [Related]
3. New insights into the endocrine disrupting effects of brominated flame retardants.
Legler J
Chemosphere; 2008 Sep; 73(2):216-22. PubMed ID: 18667224
[TBL] [Abstract][Full Text] [Related]
4. Assessing in-vitro estrogenic effects of currently-used flame retardants.
Krivoshiev BV; Dardenne F; Covaci A; Blust R; Husson SJ
Toxicol In Vitro; 2016 Jun; 33():153-62. PubMed ID: 26979758
[TBL] [Abstract][Full Text] [Related]
5. In silico and biological analysis of anti-androgen activity of the brominated flame retardants ATE, BATE and DPTE in zebrafish.
Pradhan A; Asnake S; Kharlyngdoh JB; Modig C; Olsson PE
Chem Biol Interact; 2015 May; 233():35-45. PubMed ID: 25818047
[TBL] [Abstract][Full Text] [Related]
6. Are brominated flame retardants endocrine disruptors?
Legler J; Brouwer A
Environ Int; 2003 Sep; 29(6):879-85. PubMed ID: 12850103
[TBL] [Abstract][Full Text] [Related]
7. QSAR modeling and prediction of the endocrine-disrupting potencies of brominated flame retardants.
Papa E; Kovarich S; Gramatica P
Chem Res Toxicol; 2010 May; 23(5):946-54. PubMed ID: 20408563
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro hormone activities of novel flame retardants TBB, TBPH and their metabolites TBBA and TBMEPH using reporter gene assays.
Klopčič I; Skledar DG; Mašič LP; Dolenc MS
Chemosphere; 2016 Oct; 160():244-51. PubMed ID: 27380226
[TBL] [Abstract][Full Text] [Related]
9. The brominated flame retardants TBECH and DPTE alter prostate growth, histology and gene expression patterns in the mouse.
Bereketoglu C; Modig C; Pradhan A; Andersson PL; Stasinopoulou S; Mitsiou DJ; Alexis MN; Olsson PE
Reprod Toxicol; 2021 Jun; 102():43-55. PubMed ID: 33848595
[TBL] [Abstract][Full Text] [Related]
10. The brominated flame retardants TBP-AE and TBP-DBPE antagonize the chicken androgen receptor and act as potential endocrine disrupters in chicken LMH cells.
Asnake S; Pradhan A; Kharlyngdoh JB; Modig C; Olsson PE
Toxicol In Vitro; 2015 Dec; 29(8):1993-2000. PubMed ID: 26318274
[TBL] [Abstract][Full Text] [Related]
11. In vitro endocrine disruption and TCDD-like effects of three novel brominated flame retardants: TBPH, TBB, & TBCO.
Saunders DM; Higley EB; Hecker M; Mankidy R; Giesy JP
Toxicol Lett; 2013 Nov; 223(2):252-9. PubMed ID: 24064184
[TBL] [Abstract][Full Text] [Related]
12. Some flame retardants and the antimicrobials triclosan and triclocarban enhance the androgenic activity in vitro.
Christen V; Crettaz P; Oberli-Schrämmli A; Fent K
Chemosphere; 2010 Nov; 81(10):1245-52. PubMed ID: 20943248
[TBL] [Abstract][Full Text] [Related]
13. Estrogenic and androgenic activity of PCBs, their chlorinated metabolites and other endocrine disruptors estimated with two in vitro yeast assays.
Svobodová K; Placková M; Novotná V; Cajthaml T
Sci Total Environ; 2009 Nov; 407(22):5921-5. PubMed ID: 19716585
[TBL] [Abstract][Full Text] [Related]
14. Effects of the brominated flame retardant TBCO on fecundity and profiles of transcripts of the HPGL-axis in Japanese medaka.
Saunders DM; Podaima M; Wiseman S; Giesy JP
Aquat Toxicol; 2015 Mar; 160():180-7. PubMed ID: 25646719
[TBL] [Abstract][Full Text] [Related]
15. The application of reporter gene assays for the detection of endocrine disruptors in sport supplements.
Plotan M; Elliott CT; Scippo ML; Muller M; Antignac JP; Malone E; Bovee TF; Mitchell S; Connolly L
Anal Chim Acta; 2011 Aug; 700(1-2):34-40. PubMed ID: 21742114
[TBL] [Abstract][Full Text] [Related]
16. Assessing oestrogenic effects of brominated flame retardants hexabromocyclododecane and tetrabromobisphenol A on MCF-7 cells.
Dorosh A; Děd L; Elzeinová F; Pěknicová J
Folia Biol (Praha); 2011; 57(1):35-9. PubMed ID: 21457653
[TBL] [Abstract][Full Text] [Related]
17. In vitro profiling of the endocrine-disrupting potency of brominated flame retardants.
Hamers T; Kamstra JH; Sonneveld E; Murk AJ; Kester MH; Andersson PL; Legler J; Brouwer A
Toxicol Sci; 2006 Jul; 92(1):157-73. PubMed ID: 16601080
[TBL] [Abstract][Full Text] [Related]
18. In vitro estrogenicity of polybrominated flame retardants.
Nakari T; Pessala P
Aquat Toxicol; 2005 Sep; 74(3):272-9. PubMed ID: 16024102
[TBL] [Abstract][Full Text] [Related]
19. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
[TBL] [Abstract][Full Text] [Related]
20. Widely used pharmaceuticals present in the environment revealed as in vitro antagonists for human estrogen and androgen receptors.
Ezechiáš M; Janochová J; Filipová A; Křesinová Z; Cajthaml T
Chemosphere; 2016 Jun; 152():284-91. PubMed ID: 26978704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
